Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07503002
PHASE1

Shortened LSD Intervention for Major Depressive Disorder

Sponsor: Johns Hopkins University

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine the safety and clinical effectiveness of a shortened lysergic acid diethylamide (LSD) experience. This will be achieved by administering the drug risperidone 45-minutes after the administration of LSD.

Key Details

Gender

All

Age Range

21 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-07-01

Completion Date

2027-12-01

Last Updated

2026-04-03

Healthy Volunteers

No

Interventions

DRUG

LSD

Participants will be administered LSD followed 45-minutes later by risperidone.

DRUG

Risperidone

Participants will be administered LSD followed 45-minutes later by risperidone.

Locations (1)

Johns Hopkins Center for Psychedelic and Consciousness Research

Baltimore, Maryland, United States